Table 1.
Demographic, clinical and laboratory characteristics in the different study groups
| Variable | Healthy controls (n = 6) | Remission SLE (n = 6) | Active SLE (n = 6) | PRES/SLE (n = 14) |
|---|---|---|---|---|
| Age (years ± s.e.m.) | 36 ± 4·1 | 34·1 ± 4·8 | 34·6 ± 4·2 | 33·3 ± 2·9 |
| SLEDAI score (points ± s.e.m.) | n.a. | 0 | 17 ± 3·07 | 7·8 ± 1·4 |
| Leucocytes (cells/µl × 103 ± s.e.m.) | n.d. | 4·95 ± 0·49 | 7·05 ± 1·25 | 10·07 ± 2·15 |
| Total lymphocytes (k/μl ± s.e.m.) | n.d. | 1250 ± 185 | 950 ± 140 | 1020 ± 188 |
| Platelets (cells/µl × 103 ± s.e.m.) | n.d. | 224 ± 19·3 | 233 ± 68·9 | 190 ± 31·4 |
| Haemoglobin (g/dl ± s.e.m.) | n.d. | 14·7 ± 0·26 | 9·88 ± 0·61 | 9·80 ± 0·65 |
Values in bold type represent P < 0·05. PRES = posterior reversible encephalopathy syndrome; s.e.m. = standard error of the mean; SLE = systemic lupus erythematosus; SLEDAI = Systemic Lupus Erythematosus Disease Activity Index; n.a. = not applicable; n.d. = not determined.